Latest news
CellFiber, Tidewave Bio to Evaluate 3D Cell Culture Platform for Scalable Manufacturing - Contract PharmaContract Pharma · Thu, 06 Aug 2026 19:42:43 GMTLilly, Amplia to Evaluate Combined Investigational Treatments for Advanced NSCLC - Contract PharmaContract Pharma · Tue, 04 Aug 2026 19:33:26 GMTAmplia's two-drug lung cancer trial is planned for late 2026 - Stock TitanStock Titan · Tue, 04 Aug 2026 12:45:00 GMT